Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

The role of natural killer cells in multiple sclerosis and their therapeutic implications.
Masitinib treatment in patients with progressive multiple sclerosis: a randomized pilot study.
Treatment Choices in Optic Neuritis: Corticosteroids, Intravenous Immunoglobulin, Plasma Exchange, or Other?
Studies on the induction of hydrocephalus and spongy degeneration by cuprizone feeding and attempts to antidote the toxicity.
Gene expression in brain during cuprizone-induced demyelination and remyelination.
Birth Outcomes in Newborns Fathered by Men with Multiple Sclerosis Exposed to Disease-Modifying Drugs.
Therapeutic plasma exchange and pregnancy: A case report and guidelines for performing plasma exchange in a pregnant patient.
MS clinical trials: what can subgroup analyses teach us?
Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial.
Neuroprotection in a novel mouse model of multiple sclerosis.
Investigations with cultured human microglia on pathogenic mechanisms of Alzheimer's disease and other neurodegenerative diseases.
Exposure levels of anti-LINGO-1 Li81 antibody in the central nervous system and dose-efficacy relationships in rat spinal cord remyelination models after systemic administration.
Delayed visual evoked response in optic neuritis.
46th Annual WCBR Winter Conference on Brain Research
Neuroprotective dimethyl fumarate synergizes with immunomodulatory interferon beta to provide enhanced axon protection in autoimmune neuroinflammation.
ACRM I American Congress of Rehabilitation
Cerebellar cortical demyelination in the murine cuprizone model.
Spectrophotometric Determination of Serum Copper with Biscyclohexanoneoxalyldihydrazone
Episode 20 with Dr. Jeffrey Cohen discussing two MS-related clinical trials
Episode 7 with Dr. Daniel Kantor on access to care
Teriflunomide reduces behavioral, electrophysiological, and histopathological deficits in the Dark Agouti rat model of experimental autoimmune encephalomyelitis.
Episode 4 with Dr. Michael Racke on the Kir4.1 potassium channel
Characterisation of microglia during de- and remyelination: can they create a repair promoting environment?
Clinical Trials
Clinical efficacy of BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis: subgroup analyses of the DEFINE study.

Pages